Singapore, Singapore

Xiao Wei Lu

This inventor holds 1 USPTO granted patent. Top assignee: Nanyang Technological University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiao Wei Lu. Retrieved from https://idiyas.com/inventor/xiao-wei-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xiao Wei Lu

Introduction

Xiao Wei Lu is a notable inventor based in Singapore, recognized for his contributions to the field of peptide nucleic acids. His innovative work has led to the development of a unique peptide nucleic acid monomer, which has significant implications in biotechnology and molecular biology.

Latest Patents

Xiao Wei Lu holds 1 patent for his invention titled "Peptide nucleic acid monomers and oligomers." This patent discloses a peptide nucleic acid monomer that features a terminal amino group and a terminal group A, connected by an aliphatic moiety. The design of this monomer is particularly noteworthy as it is free of groups that are charged under physiological conditions, making it a valuable asset in various applications.

Career Highlights

Xiao Wei Lu is affiliated with Nanyang Technological University, where he continues to advance research in his field. His academic and research endeavors have positioned him as a key figure in the study of peptide nucleic acids.

Collaborations

Xiao Wei Lu has collaborated with esteemed colleagues, including Chuan Fa Liu and Yun Zeng, who contribute to the innovative research environment at Nanyang Technological University.

Conclusion

Xiao Wei Lu's work in developing peptide nucleic acid monomers showcases his innovative spirit and dedication to advancing scientific knowledge. His contributions are expected to have a lasting impact on the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…